Ascorbic acid (intravenous)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Ascorbic acid (intravenous), covering 2013-08-20 to 2025-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer [Phase 2]